Literature DB >> 2160258

Regulation of cell growth by recombinant oncostatin M.

D Horn1, W C Fitzpatrick, P T Gompper, V Ochs, M Bolton-Hansen, J Zarling, N Malik, G J Todaro, P S Linsley.   

Abstract

Oncostatin M is a novel growth regulator originally isolated from differentiated human histiocytic lymphoma cells and activated T-lymphocytes based on its ability to inhibit the growth of A375 melanoma cells. We report here that oncostatin M is a widely acting regulator which alters the growth and/or morphology of cells derived from a variety of cancer cell types. At picomolar concentrations, recombinant oncostatin M inhibited the growth of 13/24 tumor cell lines. Six out of 7 lung cancer cell lines were inhibited by oncostatin M, but none of 6 colon cancer cell lines were affected. Oncostatin M also stimulated the growth of some normal cells (3/6), indicating that it, like many growth regulators, is bifunctional. Oncostatin M receptors appear necessary but not sufficient for a growth response to oncostatin M, since none of the cell lines lacking receptor responded to oncostatin M, whereas many but not all cell lines with receptor responded to oncostatin M. Receptor size (Mr congruent to 150,000) was similar for cells in which growth was inhibited, stimulated, or unaffected by oncostatin M.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160258     DOI: 10.3109/08977199009071502

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  18 in total

1.  Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.

Authors:  C Toniatti; A Cabibbo; E Sporena; A L Salvati; M Cerretani; S Serafini; A Lahm; R Cortese; G Ciliberto
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 2.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

3.  Oncostatin m promotes mammary tumor metastasis to bone and osteolytic bone degradation.

Authors:  Celeste Bolin; Ken Tawara; Caleb Sutherland; Jeff Redshaw; Patrick Aranda; Jim Moselhy; Robin Anderson; Cheryl L Jorcyk
Journal:  Genes Cancer       Date:  2012-02

4.  A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor.

Authors:  Srinivas Chollangi; Timothy Mather; Karla K Rodgers; John D Ash
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

5.  Resonance assignments for Oncostatin M, a 24-kDa alpha-helical protein.

Authors:  R C Hoffman; F J Moy; V Price; J Richardson; D Kaubisch; E A Frieden; J D Krakover; B J Castner; J King; C J March; R Powers
Journal:  J Biomol NMR       Date:  1996-06       Impact factor: 2.835

6.  A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system.

Authors:  Alejandro Aranda; Jaione Bezunartea; Erkuden Casales; Juan R Rodriguez-Madoz; Esther Larrea; Jesus Prieto; Cristian Smerdou
Journal:  Cell Mol Life Sci       Date:  2014-05-03       Impact factor: 9.261

7.  Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6.

Authors:  T M Rose; A G Bruce
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  Muscle cells produce a low molecular weight factor with anti-cancer activity.

Authors:  M Djaldetti; B Sredni; R Zigelman; M Verber; P Fishman
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

9.  Fuzzy clustering analysis of osteosarcoma related genes.

Authors:  Kai Chen; Dajiang Wu; Yushu Bai; Xiaodong Zhu; Ziqiang Chen; Chuanfeng Wang; Yingchuan Zhao; Ming Li
Journal:  Pathol Oncol Res       Date:  2013-11-30       Impact factor: 3.201

10.  Oncostatin M is a mitogen for rabbit vascular smooth muscle cells.

Authors:  R I Grove; C Eberhardt; S Abid; C Mazzucco; J Liu; P Kiener; G Todaro; M Shoyab
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.